The Cutera EU team was kept busy at the IMCAS World Congress in Paris in January, with many of the world’s most accomplished aesthetic physicians visiting the booth to catch a first glimpse of our game-changing acne device, AviClear*.
Despite no formal date announced for the much-anticipated launch of the technology outside of North America, IMCAS 2023 provided an opportunity for the international aesthetics market to learn more about this revolutionary acne treatment by attending the various symposiums held across the event. For example, delegates could see the device up close on the Cutera booth, where the team was providing demonstrations on some key features, including AviCool, the platform’s unique handpiece feature that delivers unmatched contact cooling capabilities to allow a quick, comfortable treatment experience.
Despite no formal date announced for the launch of the technology outside of North America, IMCAS 2023 provided an opportunity for delegates to learn more about this revolutionary acne treatment by attending symposiums held throughout the weekend, as well as gain a first-look of the device at Cutera’s booth.
The primary investigator for the technology, Dr. David Goldberg, MD, presented at several symposiums where he discussed his evaluation and findings of the novel 1726 nm wavelength for the treatment of mild, moderate, and severe acne. We were also honoured to be joined by Beverly Hills-based Plastic Surgeon and top AviClear user, Dr. Arash Moradzadeh, who discussed his experience with AviClear and how he introduces other Cutera technologies into his acne treatment plan.
*AviClear is only available in North America, but for all European-based physicians interested in this revolutionary acne treatment, please subscribe to our AviClear.eu newsletter to ensure you receive all the latest updates and information on any potential future launch first announcements.
